PMC:7274950 / 6713-8204
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T108 | 104-113 | UBERON:0002048 | denotes | pulmonary |
T109 | 180-185 | GO:0030431 | denotes | sleep |
T110 | 344-348 | UBERON:0002048 | denotes | Lung |
T111 | 965-968 | PR:Q9SMQ6 | denotes | Gb3 |
T112 | 979-985 | UBERON:0001969 | denotes | plasma |
T113 | 1241-1248 | UBERON:0000948 | denotes | cardiac |
T114 | 1333-1337 | PR:000007465 | denotes | FEV1 |
T115 | 1446-1450 | PR:000007465 | denotes | FEV1 |
T116 | 1472-1481 | UBERON:0002048 | denotes | pulmonary |
T88697 | 104-113 | UBERON:0002048 | denotes | pulmonary |
T47649 | 180-185 | GO:0030431 | denotes | sleep |
T42626 | 344-348 | UBERON:0002048 | denotes | Lung |
T90709 | 965-968 | PR:Q9SMQ6 | denotes | Gb3 |
T66110 | 979-985 | UBERON:0001969 | denotes | plasma |
T17975 | 1241-1248 | UBERON:0000948 | denotes | cardiac |
T79801 | 1333-1337 | PR:000007465 | denotes | FEV1 |
T74301 | 1446-1450 | PR:000007465 | denotes | FEV1 |
T8462 | 1472-1481 | UBERON:0002048 | denotes | pulmonary |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
190 | 232-240 | Species | denotes | patients | Tax:9606 |
191 | 315-323 | Species | denotes | patients | Tax:9606 |
192 | 376-384 | Species | denotes | patients | Tax:9606 |
193 | 475-483 | Species | denotes | patients | Tax:9606 |
194 | 611-618 | Species | denotes | patient | Tax:9606 |
195 | 770-778 | Species | denotes | patients | Tax:9606 |
196 | 854-861 | Species | denotes | tobacco | Tax:4097 |
197 | 1115-1123 | Species | denotes | patients | Tax:9606 |
198 | 1205-1212 | Species | denotes | tobacco | Tax:4097 |
199 | 1275-1282 | Species | denotes | patient | Tax:9606 |
200 | 960-968 | Chemical | denotes | lyso-Gb3 | MESH:C063288 |
201 | 104-125 | Disease | denotes | pulmonary involvement | MESH:D008171 |
202 | 129-142 | Disease | denotes | Fabry disease | MESH:D000795 |
203 | 161-172 | Disease | denotes | obstruction | MESH:D000402 |
204 | 186-191 | Disease | denotes | apnea | MESH:D001049 |
205 | 1241-1260 | Disease | denotes | cardiac involvement | MESH:D006331 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T48 | 344-348 | Body_part | denotes | Lung | http://purl.org/sig/ont/fma/fma7195 |
T49 | 979-985 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T24 | 344-348 | Body_part | denotes | Lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T44 | 129-142 | Disease | denotes | Fabry disease | http://purl.obolibrary.org/obo/MONDO_0010526 |
T45 | 180-191 | Disease | denotes | sleep apnea | http://purl.obolibrary.org/obo/MONDO_0005296 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T89 | 40-43 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T90 | 339-341 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T91 | 344-348 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | Lung |
T92 | 344-348 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | Lung |
T93 | 388-393 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | males |
T94 | 388-393 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | males |
T95 | 619-620 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T96 | 889-897 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T97 | 979-985 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T98 | 1112-1114 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
T99 | 1188-1192 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
T100 | 1188-1192 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
T101 | 1198-1204 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T21 | 965-968 | Chemical | denotes | Gb3 | http://purl.obolibrary.org/obo/CHEBI_18313 |
T22 | 1188-1192 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T32 | 161-191 | Phenotype | denotes | obstruction and/or sleep apnea | http://purl.obolibrary.org/obo/HP_0002870 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 180-185 | http://purl.obolibrary.org/obo/GO_0030431 | denotes | sleep |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T4 | 965-968 | GlycoEpitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T49 | 0-200 | Sentence | denotes | In two small retrospective studies, ERT has been reported to stabilize or even ameliorate the burden of pulmonary involvement in Fabry disease, mainly bronchial obstruction and/or sleep apnea [20,21]. |
T50 | 201-343 | Sentence | denotes | An interventional study of six patients receiving either ERT or placebo showed an increased exercise tolerance in patients receiving ERT [22]. |
T51 | 344-465 | Sentence | denotes | Lung function parameter in five patients (2 males) on ERT were followed longitudinally for an average of five years [17]. |
T52 | 466-670 | Sentence | denotes | In three patients, FVC and FEV1 increased during the treatment period, in one patient slight decrease of FVC and FEV1 were registered and in one patient a slight decrease in FVC, with an increase in FEV1. |
T53 | 671-779 | Sentence | denotes | Recently, Franzen et al. [23] reported the change in z-scores of FEV1 and FEV1/FVC over time in 53 patients. |
T54 | 780-1035 | Sentence | denotes | In the same study, they investigated whether factors related to age, sex, tobacco, phenotype, residual α-gal activity, age at ERT initiation, Mainz Severity Score Index (MSSI) and lyso-Gb3 levels in plasma may affect change in FEV1 and FEV1/FVC over time. |
T55 | 1036-1084 | Sentence | denotes | Median spirometric follow-up time was 7.7 years. |
T56 | 1085-1169 | Sentence | denotes | When considering z-scores, 27 patients (51%) developed airflow limitation over time. |
T57 | 1170-1373 | Sentence | denotes | Factors including male sex, active tobacco or past history of smoking, cardiac involvement and increased patient age at ERT initiation were associated with faster FEV1 decline in the univariate analysis. |
T58 | 1374-1491 | Sentence | denotes | These results suggest that earlier ERT initiation may help to stabilize FEV1 decline and preserve pulmonary function. |